SKP2 and breast carcinoma: Skp2 inhibits apoptosis by inducing the polyubiquitination and degradation of FOXO1 in prostate cancer [100] and induces the phosphorylation and ubiquitin-mediated degradation of PDCD4 in breast cancer to suppress apoptosis and increase cell proliferation and radiotherapy resistance [101].